Citius PharmaceuticalsCTXR 
$0.50-3.83%24h
-3.83%24h
Global rank22573
Market cap$75.66M
Change 7d-9.07%
YTD Performance-34.20%
SP500 benchmarkUnderperform
P/E-2.27
P/S0
Revenue$0
Earnings-$32.54M
Dividend yield-
Main Sector
Healthcare
Citius Pharmaceuticals (CTXR) Total Liabilities
CTXR Total Liabilities in 2022: $12.18M
According to Citius Pharmaceuticals latest financial reports the total liabilities of CTXR is $12.18M, an increase of 15.20% to 2022. At the end of 2022 company had $10.57M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Citius Pharmaceuticals is responsible for during its operational activities.
Citius Pharmaceuticals (CTXR) Total Liabilities History from 2023 to 2022
-
Value:-
CTXR Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $12.18M | 15.20% |
| 2022 | $10.57M | 9.61% |
| 2021 | $9.65M | -4.52% |
| 2020 | $10.10M | 119.26% |
| 2019 | $4.61M | 163.84% |
| 2018 | $1.75M | - |
View the Top Total Liabilies Stocks
